Jerris Laverne Raiford

Jerris Laverne Raiford

Auto-generated profile, based on publicly available information

Jerris Laverne Raiford

Division of HIV/AIDS Prevention, HIV Research Branch, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Atlanta, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2014 in American Journal of Community Psychology
Verified
Journal Article
Closed access
PDF file
JRJerris L. Raiford
Jerris L. Raiford
JHJeffrey H. Herbst
Jeffrey H. Herbst
MCMonique Carry
Monique Carry
FBFelicia A. Browne
Felicia A. Browne
IDIrene Doherty
Irene Doherty
WWWendee M. Wechsberg
Wendee M. Wechsberg

1 May 2013 in Journal of Adolescent Health
Verified
Journal Article
Closed access
JRJerris L. Raiford
Jerris L. Raiford
PSPuja Seth
Puja Seth
RDRalph J. DiClemente
Ralph J. DiClemente

11 May 2016 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
JRJerris L. Raiford
Jerris L. Raiford
GHGrace J. Hall
Grace J. Hall
RTRaekiela D. Taylor
Raekiela D. Taylor
DBDavid S. Bimbi
David S. Bimbi
JPJeffrey T. Parsons
Jeffrey T. Parsons

19 June 2012 in Journal of Urban Health
Verified
Journal Article
Closed access
PDF file
JRJerris Laverne Raiford
Jerris Laverne Raiford
PSPuja Seth
Puja Seth
NBNikia D. Braxton
Nikia D. Braxton
RDRalph J. DiClemente
Ralph J. DiClemente

12 November 2014 in Journal of the International Association of Providers of AIDS Care (JIAPAC)
Verified
Journal Article
Open access
LBLinda Beer
Linda Beer
EVEduardo E. Valverde
Eduardo E. Valverde
JRJerris L. Raiford
Jerris L. Raiford
JWJohn Weiser
John Weiser
BWBecky L. White
Becky L. White
JSJacek Skarbinski
Jacek Skarbinski
Objectives: Guidelines for antiretroviral therapy (ART) initiation have evolved, but consistently note that adherence problems should be considered and addressed. Little is known regarding the reasons providers delay ART initiation in clinically eligible patients. Methods: In 2009, we surveyed a probability sample of HIV care providers in 582 outpatient facilities in the United States and Puerto Rico with an open-ended question about nonclinical reasons for delaying ART initiation in otherwise clinically eligible patients. Results: Very few providers (2%) reported never delaying ART. Reasons for delaying ART were concerns about patient adherence (68%), patient acceptance (60%), and structural barriers (33%). Provider and practice characteristics were associated with reasons for delaying ART. Conclusion: Reasons for delaying ART were consistent with clinical guidelines and were both patient level and structural. Providers may benefit from training and access to referrals for ancillary services to enhance their ability to monitor and address these issues with their patients.

15 August 2023 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
JRJerris L PhD Raiford
Jerris L PhD Raiford
XYXin Yuan
Xin Yuan
TCTamara Ma Carree
Tamara Ma Carree
LBLinda Beer
Linda Beer
Background: Racial and ethnic disparities in antiretroviral therapy (ART) adherence and sustained viral suppression (SVS) have been documented among women with HIV. We examined factors that may account for these racial/ethnic differences among women to inform interventions that increase health equity. Methods: We used data from the 2015–2019 cycles of the Medical Monitoring Project, a probability sample of U.S. adults with diagnosed HIV. Using logistic regression with predicted marginal means, we calculated weighted prevalence differences (PDs) of ART adherence and SVS among Black, Hispanic/Latina, and White women taking ART. Using modeling with forward stepwise selection, we adjusted PDs for selected variables, including social and structural determinants of health (SDOH) factors, to examine whether magnitude of PDs was attenuated by their inclusion. We assessed relative changes between unadjusted and adjusted PDs. Results: After adjusting for poverty, transportation needs, health literacy, and gap in health insurance/coverage, the Black–White PD in adherence decreased by 11% (−16.0% to −14.2%). After adjusting for adherence, poverty, type of health insurance, and gap in health insurance/coverage, the Black–White PD in SVS reduced 37% (−7.9% to −5.0%) and was no longer statistically different. The Hispanic/Latina–White PD in adherence reduced 24% (−12.7% to −9.6%) after adjusting for poverty, health literacy, and transportation needs. The unadjusted Hispanic/Latina–White PD in SVS was not significantly different. Conclusion: Racial/ethnic disparities in HIV outcomes among women taking ART were substantially reduced after accounting for SDOH and other factors although differences remained. Structural interventions to improve SDOH are needed to improve health equity for women with HIV.